By the numbers: The rising danger of superbugs

A look at how the COVID-19 pandemic exacerbated one of the world’s greatest public health concerns.

By Karissa Waddick • July 20, 2022

Biotech R&D spending has skyrocketed, and so have opportunities for savings

With R&D costs on the rise, biotechs are embracing new strategies and technologies to make spending more efficient.

By Michael Gibney • July 19, 2022

Explore the Trendline➔

Oncology R&D

Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.   

By PharmaVoice staff

Pfizer's former R&D head takes on drug pricing misconceptions in new book

John LaMattina has something to say about the industry — and he hopes patients are listening.

By Meagan Parrish • July 19, 2022

Making moves: Agios, BeiGene, Biocom California and more announce new key hires

The latest executive personnel changes from around the industry.

By Karissa Waddick • July 18, 2022

How digital health is changing the relationship between patients and health providers

The pandemic has forced the pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes

July 18, 2022

Janssen extends LGBTQ mental health outreach beyond Pride Month

The pharma giant’s ‘Depression looks like me’ campaign assembles a ‘one stop shop’ of resources to help combat high rates of severe depression in the LGBTQ community.

By Karissa Waddick • July 14, 2022

COVID won't evolve to become 'less deadly' — and RedHill is prepping for the long haul

RedHill Biopharma’s chief operating officer, Guy Goldberg, says the company’s oral COVID-19 therapy could still be needed on a global scale.

By Kim Ribbink • July 12, 2022

Behind the new topical treatment set to disrupt the psoriasis market

Phil Brown, Dermavant’s chief medical officer, discusses VTAMA — the first topical cream approved for psoriasis in 25 years.

By Kelly Bilodeau • July 11, 2022

Why a 'fundamental shift' in regulatory submissions is on the way

Deloitte's senior manager of R&D and regulatory practices explains how technology and strategy must converge to smooth out the bulky drug approval process.

By Michael Gibney • July 11, 2022

The CEO of Dr. Reddy's N. America is using 'controlled explosions' to keep the generics giant growing

Marc Kikuchi weighs in on the company’s plans to pump up its pipeline and sales in the coming years.

By Meagan Parrish • July 7, 2022

How Big Pharma is prepping for the late 2020s patent cliff

Ratings agency Moody’s lays out the risk exposure for industry leaders.

By Kim Ribbink • July 6, 2022

Woman of the Week: CinCor Pharma's Terry Coelho

From M&Ms to biotech, the chief financial officer's sweet tooth for taking risks is paying off. 

By Taren Grom • July 6, 2022

Pharma companies take a fresh approach to inclusion in new DTC ads

AstraZeneca and Amgen are emphasizing diversity and authenticity in campaigns for lupus and severe asthma therapies.

By Karissa Waddick • July 5, 2022

Dave Ross of Seqirus talks 'milestone' influenza vax vote

In a unanimous decision, a CDC committee calls for a preferential flu vaccine recommendation for people aged 65 and older for the first time. 

By Alexandra Pecci • July 5, 2022

Biotech spotlight: Twist Bioscience aims to remove limits on drug discovery with DNA synthesis platform

As ‘the Amazon of DNA,’ Twist CSO, Aaron Sato, discusses the company’s breakthrough approach to DNA production and its expansion into drug development.

By Kim Ribbink • June 30, 2022

Woman of the Week: Novartis' Marie-France Tschudin

How the chief commercial officer and president of innovative medicines international plans to fuel growth and productivity at the company.

By Taren Grom • June 29, 2022

The scientist's struggle: Lessons from the journey of mRNA pioneers Katalin Karikó and Drew Weissman

The two Penn Medicine researchers whose work brought the mRNA vaccines into COVID-19 fruition want to see the pharma world embrace early science.

By Michael Gibney • June 29, 2022

Making moves: Walgreens, Merck, eClinical Solutions and more announce key new hires

The latest personnel changes from around the industry.

By Karissa Waddick • June 29, 2022

With abortion access restricted across the U.S., a new diagnostic aims to eliminate birth control's pain points

The hormonal and genetic test developed by Adyn is designed to predict and prevent adverse birth control side effects.

By Karissa Waddick • June 28, 2022

The oncology market is surging despite a decline in routine screenings

A new report from IQVIA reveals the current challenges — and promise — in cancer drug R&D.

By Kelly Bilodeau • June 28, 2022

A myriad of blows: Who's getting hit the hardest by the economy's troubles

The downturn shows few signs of hurting large pharma, but small biotechs and generics makers could face a credit crunch.

By Kim Ribbink • June 27, 2022

From vineyards to antivirals, Gilly Regev brings creative thinking to science

The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.

By Alexandra Pecci • June 27, 2022

4 tips for landing your next C-suite role in pharma

Even execs get the blues — and when they’re ready for a fresh start, Leslie Loveless, CEO of Slone Partners, says these dos and don’ts could make or break their next job move.

By Meagan Parrish • June 23, 2022

'Nobel Prize of pharma' helps put Huma's digital health platform on the global map

The company’s CEO explains how its Prix Galien award-winning app bridges patient care, treatment support and clinical research.

By Kim Ribbink • June 23, 2022

#DIA2022: Building 'guardrails' in the FDA's accelerated approval program

Regulatory experts weigh in on ways to enhance the controversial drug approval approach.

By Karissa Waddick • June 21, 2022